Search Results - "Sravya, Palavalasa"

Refine Results
  1. 1
  2. 2

    L1CAM Immunopositivity in Anaplastic Supratentorial Ependymomas: Correlation With Clinical and Histological Parameters by Chavali, Pooja, Rao, Shilpa, Palavalasa, Sravya, Bevinahalli, Nandeesh, Muthane, Yasha T. C., Sadashiva, Nishanth, Santosh, Vani

    “…Supratentorial ependymomas (ST EPNs) are molecularly characterized, of which the RELA fusion positive tumors are the most common and aggressive subgroup…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Granular cells in oligodendroglioma suggest a neoplastic change rather than a reactive phenomenon: case report with molecular characterisation by Rao, Shilpa, Sravya, Palavalasa, Chandran, Chitra, Saini, Jitender, Somanna, Sampath, Santosh, Vani

    Published in Brain tumor pathology (2017)
    “…Oligodendrogliomas are diffuse gliomas characterised by IDH mutation and 1p/19q co-deletion. Classical oligodendrocytes, minigemistocytes, gliofibrillary…”
    Get full text
    Journal Article
  5. 5

    Prognostic Factors and Outcomes in World Health Organization Grade 1 and Grade 2 Intracranial Meningiomas—5-Year Institutional Experience by Nadeem, Mohammed, Goyal-Honavar, Abhijit, Sravya, Palavalasa, Beniwal, Manish, Santosh, Vani, Dwarakanath, Srinivas

    Published in World neurosurgery (01-07-2024)
    “…Meningiomas are the most frequent primary intracranial tumor. While histological grade and grade of excision are established predictors of recurrence, the…”
    Get full text
    Journal Article
  6. 6

    DNAR-08. THY1 MEDIATES TREATMENT RESISTANCE IN GLIOBLASTOMA THROUGH RAPID REPAIR OF DNA DAMAGE by Basha Syed, Safiulla, Tripathy, Arushi, Ravikumar, Visweswaran, Awadia, Sahezeel, Palavalasa, Sravya, Huang, Dah-Luen, Rao, Arvind, Wahl, Daniel R, Rehemtulla, Alnawaz, Al-Holou, Wajd N

    Published in Neuro-oncology (Charlottesville, Va.) (11-11-2024)
    “…Glioblastoma (GBM) is a uniformly lethal primary intracranial neoplasm that inevitably recurs despite treatment by DNA damaging agents radiation (RT) and…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    TMET-03. REPROGRAMMING OF GLIOBLASTOMA GLUCOSE METABOLISM FUELS TUMOR GROWTH by Scott, Andrew J, Mittal, Anjali, Al-Holou, Wajd, Palavalasa, Sravya, Meghdadi, Baharan, O'Brien, Alexandra, Zhou, Weihua, Yang, Annabel, Zhao, Zitong, Lin, Angelica, Tarnal, Vijay, Lyssiotis, Costas, Nagrath, Deepak, Wahl, Daniel R

    Published in Neuro-oncology (Charlottesville, Va.) (10-11-2023)
    “…Metabolic adaptation can promote oncogenic phenotypes in glioblastoma (GBM), but the metabolic pathways utilized by GBM and how they differ from the pathways…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Chitinase 3-Like 2 by Nimbalkar, Vidya P, Kruthika, Banavathy S, Sravya, Palavalasa, Rao, Shilpa, Sugur, Harsha S, Chickabasaviah, Yasha T, Somanna, Sampath, Arivazhagan, Arimappamagan, Kondaiah, Paturu, Santosh, Vani

    Published in American journal of clinical pathology (06-10-2022)
    “…Abstract Objectives We aimed to evaluate the expression pattern of chitinase 3-like 2 (CHI3L2) in the tumor core and peritumoral brain zone (PBZ) of newly…”
    Get full text
    Journal Article
  14. 14

    Abstract 1789: Machine learning-based method to analyze metabolic fluxes of patient tumors by Meghdadi, Baharan, Mittal, Anjali, Scott, Andrew J., Palavalasa, Sravya, Wahl, Daniel R., Nagrath, Deepak

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…Personalized oncology must overcome the complex challenge of distinct cancer phenotypes in each patient, formed in part in response to unique metabolic…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    IRX1 is a novel gene, overexpressed in high-grade IDH-mutant astrocytomas by Sugur, Harsha S., Rao, Shilpa, Sravya, Palavalasa, Athul Menon, K., Arivazhagan, Arimappamagan, Mehta, Bhupesh, Santosh, Vani

    Published in Pathology, research and practice (01-05-2023)
    “…IDH-mutant astrocytomas include CNS WHO grade 2 (A2), grade 3 (A3) and grade 4 (A4), of which A3 and A4 are high-grade. A3 has a heterogenous clinical outcome…”
    Get full text
    Journal Article
  19. 19

    CBMT-24. MITOCHONDRIAL DNA CONTENT IN GLIOBLASTOMA AND ITS CLINICAL SIGNIFICANCE by Sravya, Palavalasa, Rao, Shilpa, Nimbalkar, Vidya, Kanuri, Nandaki, Banavathy, Kruthika, Arimappamagan, Arivazhagan, Somanna, Sampath, Santosh, Vani

    Published in Neuro-oncology (Charlottesville, Va.) (05-11-2018)
    “…Abstract Evidence of altered mitochondrial DNA (mtDNA) content in several malignancies has surfaced in recent years. However, in glioblastoma, this aspect…”
    Get full text
    Journal Article
  20. 20

    Low mitochondrial DNA copy number is associated with poor prognosis and treatment resistance in glioblastoma by Sravya, Palavalasa, Nimbalkar, Vidya Prasad, Kanuri, Nandaki Nag, Sugur, Harsha, Verma, Brijesh Kumar, Kundu, Paramita, Rao, Shilpa, Uday Krishna, A.S., Somanna, Sampath, Kondaiah, Paturu, Arivazhagan, Arimappamagan, Santosh, Vani

    Published in Mitochondrion (01-11-2020)
    “…•Mitochondrial DNA (mtDNA) copy number is a prognostic marker in glioblastoma (GBM).•Low mtDNA copy number in GBM is associated with poor prognosis.•Recurrent…”
    Get full text
    Journal Article